ASCO 2025 – Hormone Therapy in HR+ mBC with Dr. Kim Ma

Dr. Kim Ma shares post-ASCO reflections on the evolving landscape of hormone therapy in metastatic hormone receptor–positive breast cancer, highlighting exciting advancements shaping treatment strategies ahead.